Full Text
CO204 Primary and Secondary Endpoints Used in Recent (2022) Alzheimer’s Disease (AD) Phase III Clinical Trials

Abstract

Authors

R. Arjunji J. Massey B. Maru E. Crosland S. Gregory R. Kern

Back to Volume 26, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×